多替阿巴拉米片多少钱一盒
On January 22, 2018, Glaxo announced that its joint venture ViiV Healthcare’s single-pill compound preparation for the treatment of HIV, which is based on the new generation integrase inhibitor Tyvicat, was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.
Many patients ask how much a box of Docete Abalamid tablets costs. It is understood that the price of Doceta Abalamid tablets in India is about $900, and the specification is 30 tablets. Patients can go abroad to purchase in person, or choose regular overseas medical service agencies, such as Medical Companion Travel. We will provide you with legal channels to purchase medicines, and you don’t have to worry about the source of the medicines.
Everyone's risk of contracting HIV is different, and risk levels depend on lifestyle. Based on the chances of contracting HIV, people with sexually promiscuous behaviors are at high risk for contracting HIV. Those who lead chaotic lifestyles and are more frequently exposed to HIV are at high risk for HIV infection. HIV infection is more likely to be detected in these groups.
Dolutegravir tablets are a compound preparation. Each tablet contains dolutegravir sodium (calculated as dolutegravir) 50 mg, abacavir sulfate (calculated as abacavir 600 mg) and lamivudine 300 mg. It is suitable for the treatment of adults infected with human immunodeficiency virus (HIV) and adolescents over 12 years old (weight at least 40 kg) Among them, doslavir can inhibit HIV integrase through the strand transfer step (a key step in the HIV replication cycle), which binds to the active site of the integrase and blocks the integration of reverse-transcribed DNA (DNA). Patients should take doptabalamid tablets under the guidance of a doctor.
It has been approved for marketing in many countries and has been recommended by many authoritative academic institutions in Europe and the United States as a first-line treatment drug for first-time AIDS patients. It can also become a treatment option for domestic AIDS patients.
Recommended related hot articles: /newsDetail/85224.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)